Table 4 Clinicopathologic characteristics of 202 patients and expression of CENP-F
Factors | N (%) |
|---|---|
Gender | Â |
   Male | 151 (74.8) |
   Female | 51 (25.2) |
Age (y) | Â |
   ≤ 45 | 90 (44.6) |
   > 45 | 112 (55.4) |
Histologic classification (WHO) | Â |
   Type II | 10 (5.0) |
   Type III | 192 (95.0) |
Clinical stage (92 stage) | Â |
   I | 27 (13.4) |
   II | 59 (29.2) |
   III | 49(24.2) |
   IV | 67 (33.2) |
T classification | Â |
   T1 | 83 (41.1) |
   T2 | 41 (20.3) |
   T3 | 40 (19.8) |
   T4 | 38(18.8) |
N classification | Â |
   N0 | 118 (58.4) |
   N1 | 33 (16.3) |
   N2 | 29 (14.4) |
   N3 | 22 (10.9) |
Distant metastases | Â |
   No | 177 (87.6) |
   Yes | 25 (12.4) |
Living status (at last follow-up) | Â |
   Alive | 114 (56.4) |
   Death from NPC | 88(43.6) |
Skull-base invasion | Â |
   No | 159(78.7) |
   Yes | 43 (21.3) |
Expression of CENP-F | Â |
   Low | 104 (51.5) |
   High | 98 (48.5) |